Status:
RECRUITING
Psychometric Validation of the Camouflaging Autistic Traits Questionnaire
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
13-21 years
Brief Summary
For many affected individuals, despite impairment and distress, autism spectrum disorder (ASD) is recognized and diagnosed late, in school age, adolescence, or even in adulthood, which could be due, a...
Eligibility Criteria
Inclusion
- Inclusion Criteria study group:
- \- patients who meet the principal diagnosis of ASD, which includes atypical autism (ICD-10: F84.1) and Asperger syndrome (ICD-10: F84.5), and are between the ages of 13 and 21 years old.
- Exclusion Criteria study group:
- Dementia / below average cognitive abilities (IQ \< 85)
- lack of German language skills
- severe visual or hearing impairment (uncorrected)
- Inclusion Criteria control group:
- \- Adolescents who do not have a lifetime principal diagnosis of a psychiatric disorder (ICD-10-GM-2016: F10 - F69) and are between 13 and 21 years old.
- Exclusion Criteria Control Group:
- dementia / below average general cognitive ability (IQ \< 85)
- lack of German language skills
- severe impairment of vision or hearing (not corrected).
Exclusion
Key Trial Info
Start Date :
February 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
622 Patients enrolled
Trial Details
Trial ID
NCT05989685
Start Date
February 20 2023
End Date
September 1 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20251